Types of ADHD Medication: A Complete Guide to Your Options
Author:
Blossom Editorial
Medication is one of the most effective treatments for managing attention-deficit/hyperactivity disorder (ADHD), and there are more options today than many people realize. The two main categories are stimulants and non-stimulants. Within each are several medications that work in different ways, last for different lengths of time, and suit different people.
Knowing how they compare can help you have a more informed conversation with your provider.
Key Takeaways
Two main categories: ADHD medications include stimulants and non-stimulants. Stimulants are usually recommended first-line treatment, while non-stimulants may be helpful when stimulants are not a good fit or need extra support.
They work on brain chemicals: Most ADHD medications improve focus and reduce impulsivity by affecting the level of dopamine, norepinephrine, or both.
The right choice is personal: The best medication for you depends on your symptoms, health history, other conditions or medications, and how your body responds. Finding the right fit is often a step-by-step process guided by a provider.
How ADHD Medications Work
Most ADHD medications work by increasing the activity of two brain chemicals, dopamine and norepinephrine. These neurotransmitters help the brain regulate attention, motivation, and impulse control, largely through a region in the brain called the prefrontal cortex.
In people with ADHD, the signaling of these chemicals is affected. ADHD medications can improve signaling in these pathways, which may help reduce symptoms such as inattention and impulsivity.
The two main categories work in different ways. Stimulants generally act quickly and are considered first-line treatment, while non-stimulants work more gradually but can be a better fit for some people.
The National Institute of Mental Health (NIMH) suggests that medication and therapy are the most effective treatments for ADHD, and the two are often used together for the best results.
Stimulant Medications
Stimulants are the most commonly prescribed and best studied ADHD medications. Clinical guidance generally recommends them as a first-line medication option. Despite the name, they do not simply make you feel alert; stimulants increase activity in the brain. They help the brain filter distractions and sustain attention. Stimulants fall into two families: methylphenidate and amphetamine. Both are controlled substances that require careful prescribing and monitoring due to their misuse potential.
Methylphenidate
Methylphenidate is a stimulant approved to treat ADHD in adults and children 6 years and older. It works mainly by blocking the reuptake of dopamine and norepinephrine, which keeps more of these chemicals active in the brain.
It is one of the oldest and most studied ADHD medications, and is available in both short-acting and long-acting forms. Common brand names include Ritalin and Concerta. The specific formulation affects how quickly the medication starts working and how long its effects last. .
Dexmethylphenidate
Dexmethylphenidate, sold as Focalin, is a stimulant closely related to methylphenidate. It contains only the more active form of methylphenidate and can sometimes achieve symptom relief at a lower dose.
It is available in both immediate-release and extended-release forms.
Amphetamine
Amphetamine based medications are the other main stimulant family used to treat ADHD. In addition to blocking the reuptake of dopamine and norepinephrine, research suggests amphetamines can also increase the release of these neurotransmitters. This gives them a slightly different action than methylphenidate.
This family includes mixed amphetamine salts, sold as Adderall, and dextroamphetamine, sold as Dexedrine. Some people may respond better to one stimulant family than the other, which is why a provider may switch between them.
Lisdexamfetamine (Vyvanse)
Lisdexamfetamine, sold as Vyvanse, is a longer-acting amphetamine with a different design from many other stimulants. It is a prodrug, meaning it is inactive until the body converts it into active dextroamphetamine, as described in its FDA prescribing information.
This gradual activation gives it a relatively gradual onset and extended effect throughout the day. This may also lower the potential for its misuse compared with some other stimulants.
Short-Acting Versus Long-Acting Formulations
Stimulants also differ by how long they last, and this often matters as much as the medication itself.
Short-acting forms generally work quickly but may last only for a few hours. This can be useful for targeted coverage or fine-tuning a dose.
Long-acting forms release medication gradually so a single morning dose can last most of the day. This can help improve consistency and reduce the need for a midday dose. The table below shows a general comparison of how long different medications can last.
Formulation | Example brands | Approximate duration |
|---|---|---|
Short-acting (immediate-release) | Ritalin, Adderall, Focalin | About 3 to 5 hours |
Intermediate-acting | Ritalin SR, Adderall (twice daily) | About 6 to 8 hours |
Long-acting (extended-release) | Concerta, Adderall XR, Vyvanse | About 8 to 13 hours |
These are general time ranges and can vary by medication, formulation, dose, and individual response. Long-acting options can reduce the need for additional doses during the day. On the other hand, short-acting options may provide more flexibility when shorter periods of symptom coverage are needed.
Some stimulant medications also include non-oral delivery, such as a methylphenidate skin patch. This can be helpful for people who have trouble swallowing pills. Choosing a formulation is part of tailoring treatment to your daily routine and how long you need symptom coverage.
Common Stimulant Side Effects
Stimulants can be effective for ADHD, but they can also cause side effects. Common effects include reduced appetite, trouble sleeping, headache, increased heart rate or blood pressure, and irritability. The type and severity of side effects can vary from person to person and may depend on the medication and dose.
Since stimulants can be misused, they are classified as controlled substances, and providers monitor their use closely. They may not be the best option for people with certain heart conditions or a history of substance misuse, which is where non-stimulants can play an important role.
Non-Stimulant Medications
When stimulants are not a good fit, whether because of side effects, other health conditions, or personal preference, non-stimulant medications may offer an effective alternative.
Unlike stimulants, non-stimulants are not controlled substances. They generally take longer to produce their full effects, but some can provide more consistent symptom coverage throughout the day. You can see a more detailed overview on non-stimulant ADHD medication.
Atomoxetine (Strattera)
Atomoxetine, sold as Strattera, was the first non-stimulant approved for ADHD. Its FDA label describes it as a selective norepinephrine reuptake inhibitor (SNRI), meaning it can increase norepinephrine levels without acting like a stimulant. It can help improve attention and reduce ADHD symptoms.
Atomoxetine is not a controlled substance and has a lower potential for misuse than stimulant medications. Due to this, it can be a good option for people with a history of substance concerns. It is taken every day and usually takes several weeks to reach its full effect.
Viloxazine (Qelbree)
Viloxazine, sold as Qelbree, is a newer non-stimulant approved for ADHD in adults and children 6 years and older. Research describes it as affecting norepinephrine signaling as well as serotonin activity.
Like other non-stimulants, it is not a controlled substance and is available as a once-daily medication. It can be a better option for people who cannot take stimulants or prefer to avoid them.
Guanfacine (Intuniv)
Guanfacine, sold in its extended-release form as Intuniv, belongs to a group of medications called alpha-2 adrenergic agonists. It works differently from stimulants and may help strengthen norepinephrine signaling in the prefrontal cortex. This region of the brain is involved in attention and impulse control.
Research on alpha-2 agonists for ADHD suggests they can be used on their own or added to a stimulant. Guanfacine tends to be less sedating than clonidine, which is one reason it is sometimes preferred.
Clonidine (Kapvay)
Clonidine, sold in its extended-release form as Kapvay, is another alpha-2 agonist used to treat ADHD. It works similarly to guanfacine but tends to be more calming for ADHD, which can help when a person also struggles with sleep problems, tics, or high levels of restlessness. Like guanfacine, it can be used alone or alongside a stimulant, and it usually takes a few weeks to reach its full effect.
Off-Label Options
Providers sometimes use medications that are not formally approved for ADHD when standard options are not suitable. Off-label means prescribing a medication for a condition it is not specifically approved for. This does not mean the medication is experimental rather providers may consider off-label treatment when clinical evidence supports its use.
One example is bupropion, an antidepressant that raises dopamine and norepinephrine and is sometimes used off-label for ADHD. Some research suggests it may help reduce ADHD symptoms, particularly when depression is also present. It is not a stimulant, a distinction covered in content on whether Wellbutrin is a stimulant.
Stimulants Versus Non-Stimulants: A Quick Comparison
Choosing between the two categories can depend on several factors including how quickly you need results, your health history, and how your body responds. The table below summarizes some general differences.
Feature | Stimulants | Non-Stimulants |
|---|---|---|
Speed of effect | Often within hours | Usually weeks |
Controlled substance | Yes | No |
First-line use | Usually tried first | Often second choice, when stimulants are not a good fit |
Misuse potential | Present | Generally lower |
Examples | Ritalin, Adderall, Vyvanse | Strattera, Qelbree, Intuniv |
Research comparing the two suggests that stimulants tend to produce somewhat stronger effects on ADHD symptoms. This is why they are usually recommended first. Even so, non-stimulants are a valuable and effective choice for many people. In some cases, the two can also be combined.
Here you can read more about stimulant and non-stimulant options.
Can You Combine ADHD Medications?
Sometimes one medication is not enough on its own, and a provider may recommend combining two. This is done carefully and under close supervision, but it is a recognized strategy backed by clinical guidance.
A common approach pairs a stimulant with an alpha-2 agonist such as guanfacine or clonidine. Treatment guidelines suggest that combining a stimulant and a non-stimulant can help improve symptom control when a single medication provides only partial benefit.
This combination can also help smooth out the end of the day as a stimulant wears off, or address extra symptoms such as trouble sleeping. Because combining medications can increase the potential for side effects and interactions, combination treatment should be planned and monitored by a healthcare provider.
Dosing, Titration, and Monitoring
Finding the right medication and the right dose is a gradual process rather than a one-time decision. Providers usually start with a lower dose and gradually adjust it based on symptom improvement, side effects, and individual response. This process is called titration and is a normal part of treatment.
Cardiovascular checks: Because stimulants and some non-stimulants can raise heart rate and blood pressure, providers often check these before and during treatment. Reviews of cardiovascular safety in ADHD treatment suggest routine monitoring, especially for people with heart concerns.
Growth monitoring in children: Stimulants can temporarily reduce appetite and may slow growth in some children, so height and weight are tracked over time. Research on stimulants and adult height suggests most children catch up, though long-term monitoring is still recommended.
Side effect review: Regular check-ins help catch issues such as sleep changes, mood shifts, or reduced appetite early so the plan can be adjusted.
Ongoing follow-up: ADHD symptoms and treatment needs can change over time. Therefore, follow-ups can help providers determine the appropriate treatment plan for you.
What If the First Medication Does Not Work?
It is common for the first medication or dose not to be the perfect fit, and this does not mean treatment has failed. There are several clear next steps a provider can take, and many people find the right match with some adjustment.
Adjust the dose: Sometimes a higher or lower dose may make a meaningful difference in improving symptoms or reducing side effects.
Switch within a class: If one stimulant family does not seem to be helpful or well-tolerated, switching to the other might help. For example, from methylphenidate to amphetamine based medication.
Switch classes: Moving from a stimulant to a non-stimulant can also help, especially when stimulants tend to be less effective or cause bothersome side effects.
Add a second medication: Combining a stimulant with an alpha-2 agonist can help when a single medication does not fully address the symptoms on its own.
This is why an accurate diagnosis and ongoing follow-up matter so much, and understanding who can diagnose ADHD can help you get started. Similarly, finding the most effective ADHD medication for adults is often a step-by-step process rather than a single decision.
How Providers Choose a Medication
There is no single best ADHD medication that works for everyone. Providers weigh several factors when recommending a starting point, and personal circumstances often guide the choice.
These include:
Symptom pattern: Whether inattention, hyperactivity, or impulsivity is most prominent.
Other conditions: Co-occurring anxiety, tics, sleep problems, or a history of substance misuse can also steer the choice. For example, some people may benefit from a different approach when ADHD occurs alongside anxiety, as discussed in the best ADHD medication for adults with anxiety.
Health history: Heart conditions, blood pressure, and other medications can all influence medication choices.
Daily needs: How long coverage is needed during the day can help guide whether short-acting or long-acting forms are more appropriate.
Response and tolerance: How well you respond and what side effects you notice can help shape ongoing adjustments.
How Blossom Health Can Help
If you think ADHD medication might help, working with a licensed psychiatric provider is the safest and most effective way to explore your options. Blossom Health connects you with board-certified providers for virtual, in-network care through a simple process.
Step one: Enter your state of residence and insurance plan so we can match you with the right provider.
Step two: Choose an appointment time that fits your schedule, often within days.
Step three: Share a few details about yourself and your insurance to confirm your first visit.
Your provider can help evaluate your symptoms, review your history, and build a treatment plan that may include medication, therapy, or both. When you are ready, you can get started with Blossom Health and take the next step toward better focus.
Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. The information provided should not replace consultation with a qualified healthcare provider. Individual responses to medications can vary significantly, and what applies to one person may not be the same for another.
Always consult with your doctor or pharmacist before making any decisions about medication changes, discontinuation, or interactions with other substances. If you’re experiencing concerning symptoms or side effects, please seek professional help from a healthcare provider.
In case of a medical emergency, contact your local emergency services immediately or call 911. For mental health emergencies, contact the National Suicide Prevention Lifeline at 988.
Sources
Farzam K, Faizy RM, Saadabadi A. Stimulants. [Updated 2023 Jul 2]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK539896/
Verghese C, Patel P, Abdijadid S. Methylphenidate. [Updated 2024 Oct 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482451/
Martin D, Le JK. Amphetamine. [Updated 2023 Jul 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK556103/
Fedder D, Patel H, Saadabadi A. Atomoxetine. [Updated 2023 Mar 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK493234/
Attention-Deficit/Hyperactivity Disorder Medications for Adults: Drugs [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Nov. Available from: https://www.ncbi.nlm.nih.gov/books/NBK610422/
Robinson, C. L., Parker, K., Kataria, S., Downs, E., Supra, R., Kaye, A. D., Viswanath, O., & Urits, I. (2022). Viloxazine for the Treatment of Attention Deficit Hyperactivity Disorder. Health psychology research, 10(3), 38360. https://doi.org/10.52965/001c.38360
Hanwella, R., Senanayake, M., & de Silva, V. (2011). Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis. BMC psychiatry, 11, 176. https://doi.org/10.1186/1471-244X-11-176
Neuchat, E. E., Bocklud, B. E., Kingsley, K., Barham, W. T., Luther, P. M., Ahmadzadeh, S., Shekoohi, S., Cornett, E. M., & Kaye, A. D. (2023). The Role of Alpha-2 Agonists for Attention Deficit Hyperactivity Disorder in Children: A Review. Neurology international, 15(2), 697–707. https://doi.org/10.3390/neurolint15020043
Wojnowski, N. M., Zhou, E., & Jee, Y. H. (2022). Effect of stimulants on final adult height. Journal of pediatric endocrinology & metabolism : JPEM, 35(11), 1337–1344. https://doi.org/10.1515/jpem-2022-0344
Hammerness, P. G., Perrin, J. M., Shelley-Abrahamson, R., & Wilens, T. E. (2011). Cardiovascular risk of stimulant treatment in pediatric attention-deficit/hyperactivity disorder: update and clinical recommendations. Journal of the American Academy of Child and Adolescent Psychiatry, 50(10), 978–990. https://doi.org/10.1016/j.jaac.2011.07.018
U.S. Food and Drug Administration. (September, 2025). Vyvanse (lisdexamfetamine dimesylate): Prescribing information. accessdata.fda.gov
U.S. Food and Drug Administration. (January, 2022). Strattera (atomoxetine): Prescribing information. accessdata.fda.gov
National Institute of Mental Health. (August, 2026). Attention-Deficit/Hyperactivity Disorder (ADHD).https://www.nimh.nih.gov/health/topics/attention-deficit-hyperactivity-disorder-adhd
Centers for Disease Control and Prevention (CDC). (July 30, 2026). ADHD in Adults. https://www.cdc.gov/adhd/about/adhd-in-adults.html
